Article
Neurocognitive functioning in long-term survivors of glioblastoma, IDH-wildtype and astrocytoma, IDH-mutant, CNS WHO grade 4: A report from EORTC 1419 (ETERNITY).
European journal of cancer (Oxford, England : 1990) - 5 Oct 2026
Drijver A Josephine, Butterbrod Elke, Hertler Caroline, Frances Sé M, Reifenberger Guido, Felsberg Jörg, Gorlia Thierry, van den Dobbelsteen Emmie M C, de Boer Noor, Rudà Roberta, Pellerino Alessia, Clarke Jennifer, Kumar-Wessel Karishma, Tabouret Emeline, Schnell Oliver, Wick Wolfgang, Darlix Amélie, Lombardi Giuseppe, van den Bent Martin, Ducray Francois, Ronellenfitsch Michael W, Hau Peter, Thon Niklas, Preusser Matthias, Le Rhun Emilie, Wen Patrick Y, Reijneveld Jaap C, Weller Michael, Klein Martin
Abstract excerpt
BACKGROUND: ETERNITY was a retrospective and prospective cohort study investigating long-term (≥5 years) survival in patients with glioblastoma. We assessed the longitudinal course of neurocognitive function (NCF) and its determinants in a subgroup of patients with glioblastoma, IDH-wildtype, or astrocytoma, IDH-mutant, CNS WHO grade 4. METHODS: NCF was assessed at baseline and every 6 months using the Hopkins...
Read the complete abstract on PubMedTopics
- Humans
- Female
- Isocitrate Dehydrogenase